Group G streptococcal arthritis

Area of Science:

• Clinical microbiology and infectious diseases.
• Rheumatology and immunology.
• Oncology and internal medicine.

Background:

• Septic arthritis is a serious joint infection requiring prompt diagnosis and treatment.
• Lancefield Group G streptococcus is a less common bacterial cause of bloodstream and soft tissue infections.
• Understanding the clinical spectrum and risk factors for rare pathogens is crucial for effective patient management.

Observation:

• Six cases of Lancefield Group G streptococcal septic arthritis were identified.
• Pre-existing chronic arthritis (including rheumatoid arthritis) and joint prosthesis infection were noted in two patients.
• Neoplastic disease was present in three patients, either preceding or concurrent with septic arthritis.
• Prominent skin manifestations, such as cellulitis and scarlatiniform rash, occurred in five cases.
• A potential zoonotic transmission from a pet dog was observed in one instance.
• The unusual association of Group G streptococcus with specific patient populations and clinical presentations is highlighted.

Findings:

• Five patients achieved a favorable response to penicillin therapy.
• One patient, allergic to penicillin, was successfully treated with erythromycin.
• The study demonstrates the efficacy of standard antibiotic regimens for this specific pathogen.
• The increasing recognition of Group G streptococcal arthritis in the United Kingdom is noted.

Implications:

• Clinicians should consider Lancefield Group G streptococcus in the differential diagnosis of septic arthritis, particularly in immunocompromised individuals or those with chronic joint disease.
• Early recognition and appropriate antibiotic selection are key to favorable outcomes.
• Further surveillance may be warranted to understand the epidemiology and clinical significance of this emerging infectious cause of arthritis.